Celebrex (celecoxib), the first COX-2 inhibitor

Searle and Pfizer are now marketing Celebrex (celecoxib), the first COX-2 inhibitor...in both the U.S. and Canada.

A second one, Vioxx (rofecoxib, Merck) is expected soon.

Celebrex and Vioxx will be used as alternatives to NSAIDs for arthritis and pain.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote